IRCT20210201050197N3已完成未知
Single-dose bioequivalence studies of Gemifloxacin tablets (320 mg) in healthy volunteers
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •Healthy volunteer
- •Age: 18-50 year
排除标准
- •History of liver, kidney and cardiovascular diseases that can affect drug clearance from body
- •History of taking any medication in the last two weeks
- •Creatinine above 2
研究者
相似试验
尚未招募
4 期
Bioequivalence study of levofloxacin 750 mg tablet in Thai healthy volunteersThai healthy male and female subjects ,Aged 18 †50 years ,BMI were within 18ᆭ kg/m2 ,Good health confirming by physical and clinicalTCTR20190627002Faculty of Medicine, Chulalongkorn University26
尚未招募
不适用
Comparative in vivo evaluation of 2 Glibenclamide 5 mg Tablet formulations.Diabetes Mellitus.Type 2 diabetes mellitusIRCT20180620040164N32Dorsa Pharmaceutical Co.24
已完成
不适用
bioequivalence of febuxostatIRCT20200705048005N1ChemiDaru Pharmaceutical Company26
尚未招募
1 期
Single-Dose, Fed Bioequivalence study of Mylan Esomeprazole 40 mg DR tablets; Mylan Laboratories Limited, India relative to Nexium® 40 mg tablets of AstraZeneca in healthy Thai volunteersBioequivalence studyEsomeprazoleTCTR20200630001Bio-innova and Synchron.Co.,Ltd48
尚未招募
1 期
Single-Dose, Fed Bioequivalence Study of MYLAN Rivaroxaban Tablets 20 mg (20 mg; Mylan) and Xarelto® 20 mg (20 mg; Bayer) in Healthy Adult VolunteersBioequivalence Study,Healthy,Thai VolunteersRivaroxaban ,TCTR20201224002International Bio Service Co.,Ltd.36